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Abstract
Background: Low Back Pain is a major public health problem all over the western world. Active
approaches including exercise in the treatment of low back pain results in better outcomes for patients,
but it is not known exactly which types of back exercises are most beneficial or whether general physical
activity provide similar benefits.
Nordic Walking is a popular and fast growing type of exercise in Northern Europe. Initial studies have
demonstrated that persons performing Nordic Walking are able to exercise longer and harder compared
to normal walking thereby increasing their cardiovascular metabolism. Until now no studies have been
performed to investigate whether Nordic Walking has beneficial effects in relation to low back pain.
The primary aim of this study is to investigate whether supervised Nordic Walking can reduce pain and
improve function in a population of chronic low back pain patients when compared to unsupervised
Nordic Walking and advice to stay active. In addition we investigate whether there is an increase in the
cardiovascular metabolism in persons performing supervised Nordic Walking compared to persons who
are advised to stay active. Finally, we investigate whether there is a difference in compliance between
persons receiving supervised Nordic Walking and persons doing unsupervised Nordic Walking.
Methods: One hundred and fifty patients with low back pain for at least eight weeks and referred to a
specialized secondary sector outpatient back pain clinic are included in the study. After completion of the
standard back centre treatment patients are randomized into one of three groups: A) Nordic Walking
twice a week for eight weeks under supervision of a specially trained instructor; B) Unsupervised Nordic
Walking for eight weeks after one training session with an instructor; C) A one hour motivational talk
including advice to stay active. Outcome measures are pain, function, overall health, cardiovascular ability
and activity level.
Results: No results available at this point.
Discussion: This study will investigate the effect of Nordic Walking on pain and function in a population
of people with chronic LBP. 
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Background
Low back pain (LBP) is a major public health problem all
over the western world and one of the leading causes for
sick leave and disability [1]. In Denmark, 35–50% of the
adult population have suffered from LBP, in the last year,
and 21% have had symptoms the past 14 days [2]. There-
fore high quality research aiming at identifying effective
treatment and prevention strategies is warranted.
Throughout the last three decades the management of LBP
has changed radically from primarily passive treatments
and bed rest to patient centred active treatments involving
exercise, resulting in improved outcomes with regards to
pain, daily function, and return to work [3-5]. As a result
of this development, a wide variety of specific exercise
regimes have emerged, however, there is little evidence
that one type of exercise is superior to another in the treat-
ment of LBP, even though sub-groups of patients benefit-
ing from specific exercise interventions have been
identified [5]. Based on results from a recent randomized
clinical trial Hurwitz et al. went as far as to suggesting that
maybe LBP patients should refrain from back specific
exercises and instead focus on non-specific physical activ-
ities in order to reduce pain and improve health [6],
thereby adding LBP to the already long list of health con-
ditions that are influenced positively by physical activity.
Nordic Walking (NW) is a fast growing and popular way
to exercise in northern Europe, in particular in Scandina-
via and Germany [7]. NW is low-tech and cheap; it doesn't
require a lot of skill and can be done by almost anybody.
NW is performed by walking using poles with rubber or
spike tips in the same way as in Nordic style skiing. By
using the poles the muscles in the upper body are acti-
vated and the length of each step taken is increased result-
ing in a faster gait. Consequently, NW appears to increase
cardiovascular metabolism even in healthy people [8,9].
So far the effect of NW on pain and disability in relation
to LBP has not been investigated however if shown effec-
tive, NW would constitute an attractive low-tech, low-risk,
and low-cost intervention. Furthermore, it is not known
whether LBP patients are willing to comply with the pre-
scribed dose and frequency, a problem commonly
encountered in other forms of exercise therapy for LBP
[10], and whether compliance plays a role in relation to
pain and disability outcomes.
The primary aim of this single blind randomized clinical
trial is therefore to compare the effect of supervised NW
versus non-supervised NW versus information about the
benefits of physical activity in relation to pain and pain
related function using standardized outcome measures.
Secondary objectives are 1) to compare the increase in car-
diovascular metabolism between the supervised NW
group and the information group and 2) to evaluate com-
pliance to NW between the supervised and non-super-
vised NW group.
Methods
Design
Singleblinded Radomized Clinical Trial.
Study sample
The patients are recruited from a secondary sector special-
ized out-patient back pain clinic. All participants receive
information about self-care for back pain and attend
group exercises twice a week for four weeks before being
offered inclusion into the current project. 50 patients are
to be included in each of the three intervention groups,
totalling 150 participants.
Inclusion/exclusion
To be included in the project participants must
￿ have had LBP with or without leg pain > 8 weeks
￿ have received four weeks of treatment in the primary sec-
tor by a family physician, chiropractor, physical therapist,
or a combination thereof
￿ have ended all examinations, individual and group
treatment at the back clinic with at least a 75% attendance
rate
￿ be able to read and understand Danish
Exclusion criteria are
￿ pain less than 3 on the 11 point numeric rating scale
￿ co-morbidity preventing patient from participating in
the full intervention
￿ unable to sit on a stationary bike for at least 30 minutes
in order to perform watt max bicycle test
Examination and baseline data
One week after ending the group exercise program, poten-
tial participants are assessed in an individual baseline test
session. First, they complete a battery of questionnaires
including information on social, psychological, occupa-
tional, educational, physical and lifestyle factors, expecta-
tions to treatment outcome, and baseline values for the
outcome measures (see below). Finally, each participant
performs a watt max cycle test in order to evaluate their
cardiovascular capacity.
Randomization
Randomization is carried out by a project secretary
blinded to the interventions. Participants consenting toBMC Musculoskeletal Disorders 2006, 7:77 http://www.biomedcentral.com/1471-2474/7/77
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participate draw a sealed envelope containing informa-
tion about treatment allocation. Envelopes are arranged
in clusters of 15 to secure an even spread in all groups.
Interventions
After test session and randomization, participants are allo-
cated to one of three groups
Group A is instructed and performs NW in groups of 6–8
twice a week for 8 weeks under supervision of a specially
trained instructor. To monitor the activity level in this
group accelerometers are provided for the participants.
The participants have to use accelerometers through out
the day for 2 weeks (week 4 and 5) during the interven-
tion. In the same period they have to fill out an exercise
dairy describing their daily activity.
Group B is instructed in NW once by a specially trained
instructor, but is afterwards told to perform NW as much
as they want to at home on their own for the next 8 weeks.
This group also reviews accelerometers and an exercise
dairy for 2 weeks (week 4 and 5 during the intervention.
Group C is given standard information about exercise and
maintaining the daily function level they have achieved
during the treatment at the back pain clinic.
NW poles are provided free of charge to everyone
included in the project. Participants randomized to group
C received their poles after completion of the 8 weeks.
Outcome measures
Primary outcome measures
Low Back Pain Rating Scale
Low Back Pain Rating Scale was developed to measure the
dimensions of pain, disability, and physical impairment
for patients with LBP [11]. The pain assessment index is
measures using three 11-box numeric rating scales (pain
now, worst and average pain in the last two weeks) for
back and leg pain separately. Each response scale score is
added giving a scale range of 0–60 points. The disability
index comprises 15 items scaled as yes = 0 points, can be
a problem = 1 point, no = 2 points, giving a total of 0–30
points
Patient Specific Function Scale
Patient Specific Function Scale was developed to assess
functional limitations in a variety of clinical presenta-
tions. Patients are asked to identify three important activ-
ities with which they are having difficulty or are unable to
perform because of their problem. In addition to specify-
ing the activities, patients are asked to rate on an 11-box
numeric rating scale the current level of difficulty associ-
ated with each activity [12]
Secondary outcome measures
EQ-5D
EQ-5D is a standardized 5-item generic measure of health
related quality of life. Domains of mobility, self-care,
usual activities, pain/discomfort, and anxiety are assessed
using a three point response scale [13].
Medication use, other treatment for LBP, time off work
Information collected using questionnaires at different
time points.
Outcome measures used in relation to objective number
two (increase in cardiovascular metabolism).
Watt Max Bicycle Test
Watt Max Bicycle Test is a standardized test to determinate
a persons cardiovascular capacity [14]. The test person
rides a stationary exercise bike and resistance I gradually
increased every three minutes until the test person reaches
the point of excursion.
Outcome measures used to collect information about
compliance
Accelerometers
Studies have shown that physical activity can be moni-
tored by accelerometers with good reliability and validity
[15-17]. In the current project the participants wear the
accelerometers the fourth and fifth week of the interven-
tion. The accelerometer (actigraph GT256) is sent by mail,
with a detailed instructions about correct use. At the end
of the two week data collection period, participants return
the accelerometer by mail and data are electronically
downloaded and stored.
Exercise dairy
The activity level is also measured subjectively using a self-
completed activity booklet. The booklet, which is filled
out in the same two weeks as the accelerometer is worn,
has previous been used in studies where subjective infor-
mation from participants regarding their level of activity
has been collected [18]. Data from the booklet will be
compared with data from the accelerometer.
Follow-up
Follow-up data are collected at eight weeks, six months
and one year (Figure 1).
Data analyses
Power is calculated based on the primary outcome meas-
ures. A sample size of 150 participants will provide 80%
power to detect a difference of one unit on the NRS (SD =
2.0) between the experimental and control group, assum-
ing alpha of 0.05. This allows for loss to follow up of 20%.BMC Musculoskeletal Disorders 2006, 7:77 http://www.biomedcentral.com/1471-2474/7/77
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Data will be analyzed by a research group member (JH)
blinded to group status. The analysis will be based on
intention to treat principles. Both parametric and non
parametric principles will be used to compare treatment
effects between the groups to identify baseline predictors
for successful treatment outcome. Finally, based on a
Figure 1
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prior definition of success, numbers needed to treat will
be calculated.
Approval
The study is approved by the regional ethics committee for
Funen and Vejle Counties, approval # VF 2005005
Discussion
This is a presentation of a RCT dealing with the effect of
Nordic Walking on pain and functional limitations in a
population of chronic LBP patients. The inclusion period
is expected to last throughout 2006, and results of the trial
will be presented as soon as they are available.
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